$11.7 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 102 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 48.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $1,647,030,000 | +7.8% | 9,300,000 | +16.4% | 14.14% | +37.1% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $721,500,000 | -48.9% | 2,616,500 | -40.3% | 6.19% | -35.0% |
| FIS | Buy | FIDELITY NATL INFORMATION SV | $562,124,000 | +15.9% | 4,621,208 | +32.6% | 4.82% | +47.5% |
| CNC | New | CENTENE CORP DEL | $430,723,000 | – | 7,250,000 | +100.0% | 3.70% | – |
| IQV | Buy | IQVIA HLDGS INC | $403,364,000 | +40.8% | 3,739,696 | +101.6% | 3.46% | +79.0% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $352,576,000 | +27.2% | 1,243,215 | +45.7% | 3.03% | +61.7% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $343,230,000 | -6.6% | 295,173 | +7.4% | 2.95% | +18.7% |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $315,595,000 | -4.8% | 723,328 | +5.9% | 2.71% | +21.2% |
| IAC | Sell | IAC INTERACTIVECORP | $307,379,000 | -40.3% | 1,715,000 | -17.0% | 2.64% | -24.1% |
| ABBV | Buy | ABBVIE INC | $304,760,000 | +37.7% | 4,000,000 | +60.0% | 2.62% | +75.1% |
| WAB | Buy | WABTEC | $304,295,000 | -22.8% | 6,322,354 | +24.7% | 2.61% | -1.9% |
| INFO | Buy | IHS MARKIT LTD | $295,532,000 | +43.0% | 4,925,538 | +79.5% | 2.54% | +81.9% |
| MSFT | Sell | MICROSOFT CORP | $287,619,000 | -16.6% | 1,823,720 | -16.6% | 2.47% | +6.1% |
| V | Buy | VISA INC | $284,098,000 | -0.7% | 1,763,268 | +15.8% | 2.44% | +26.3% |
| ANTM | ANTHEM INC | $283,800,000 | -24.8% | 1,250,000 | 0.0% | 2.44% | -4.4% | |
| GD | Buy | GENERAL DYNAMICS CORP | $275,692,000 | +59.3% | 2,083,681 | +112.3% | 2.37% | +102.6% |
| SHW | Buy | SHERWIN WILLIAMS CO | $233,955,000 | +9.0% | 509,130 | +38.4% | 2.01% | +38.7% |
| CRM | Sell | SALESFORCE COM INC | $232,454,000 | -17.1% | 1,614,488 | -6.4% | 2.00% | +5.4% |
| CI | Sell | CIGNA CORP NEW | $221,475,000 | -27.8% | 1,250,000 | -16.7% | 1.90% | -8.2% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $218,498,000 | -9.0% | 1,123,500 | -0.8% | 1.88% | +15.7% |
| XLRN | Buy | ACCELERON PHARMA INC | $195,467,000 | +84.3% | 2,175,000 | +8.8% | 1.68% | +134.4% |
| FB | Buy | FACEBOOK INCcl a | $181,399,000 | -14.2% | 1,087,524 | +5.6% | 1.56% | +9.1% |
| EQIX | Sell | EQUINIX INC | $176,087,000 | -27.5% | 281,933 | -32.3% | 1.51% | -7.9% |
| EXEL | Buy | EXELIXIS INC | $172,200,000 | +30.3% | 10,000,000 | +33.3% | 1.48% | +65.7% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $172,126,000 | -0.5% | 5,750,000 | -8.0% | 1.48% | +26.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $163,275,000 | -2.2% | 1,500,000 | +3.4% | 1.40% | +24.3% |
| PANW | Sell | PALO ALTO NETWORKS INC | $161,783,000 | -36.9% | 986,721 | -11.0% | 1.39% | -19.7% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $154,991,000 | -12.9% | 1,376,349 | +7.6% | 1.33% | +10.7% |
| TRU | Buy | TRANSUNION | $133,941,000 | +2.4% | 2,023,887 | +32.5% | 1.15% | +30.2% |
| BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $133,760,000 | +46.3% | 35,200,000 | +15.9% | 1.15% | +86.1% |
| QGEN | Buy | QIAGEN NV | $123,177,000 | +69.2% | 2,960,986 | +37.5% | 1.06% | +115.3% |
| FTSV | New | FORTY SEVEN INC | $105,439,000 | – | 1,105,000 | +100.0% | 0.90% | – |
| ENTA | ENANTA PHARMACEUTICALS INC | $90,003,000 | -16.8% | 1,750,000 | 0.0% | 0.77% | +5.9% | |
| RARX | Buy | RA PHARMACEUTICALS INC | $69,134,000 | +24.0% | 1,440,000 | +21.2% | 0.59% | +57.7% |
| FATE | Buy | FATE THERAPEUTICS INC | $66,630,000 | +51.3% | 3,000,000 | +33.3% | 0.57% | +92.6% |
| WMGI | Buy | WRIGHT MED GROUP N V | $65,179,000 | +209.9% | 2,275,000 | +229.7% | 0.56% | +293.7% |
| GRFS | GRIFOLS S Asp adr rep b nvt | $62,700,000 | -13.5% | 3,113,222 | 0.0% | 0.54% | +10.0% | |
| ZYME | Buy | ZYMEWORKS INC | $62,073,000 | -19.7% | 1,750,000 | +2.9% | 0.53% | +2.1% |
| ZGNX | Buy | ZOGENIX INC | $55,643,000 | -39.0% | 2,250,000 | +28.6% | 0.48% | -22.4% |
| FGEN | Buy | FIBROGEN INC | $55,588,000 | -4.0% | 1,599,667 | +18.5% | 0.48% | +22.0% |
| BRMK | Sell | BROADMARK RLTY CAP INC | $53,920,000 | -41.1% | 7,170,213 | -0.1% | 0.46% | -25.0% |
| PLYA | PLAYA HOTELS & RESORTS NV | $53,562,000 | -79.2% | 30,606,930 | 0.0% | 0.46% | -73.5% | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $53,580,000 | +250.0% | 2,000,000 | +300.0% | 0.46% | +346.6% |
| Buy | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $49,460,000 | +43.7% | 35,102,000 | +46.3% | 0.42% | +83.2% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $46,122,000 | +104.5% | 600,000 | +242.9% | 0.40% | +160.5% |
| EFX | Sell | EQUIFAX INC | $45,185,000 | -50.6% | 378,275 | -42.0% | 0.39% | -37.1% |
| AGIO | AGIOS PHARMACEUTICALS INC | $44,350,000 | -25.7% | 1,250,000 | 0.0% | 0.38% | -5.5% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $42,577,000 | -7.1% | 39,676,000 | 0.0% | 0.36% | +18.1% | ||
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $41,170,000 | -30.4% | 1,000,000 | +5.3% | 0.35% | -11.5% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $40,827,000 | -9.7% | 567,047 | -5.5% | 0.35% | +14.8% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $34,611,000 | – | 365,000 | +100.0% | 0.30% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $34,237,000 | – | 350,000 | +100.0% | 0.29% | – |
| VCYT | Buy | VERACYTE INC | $33,426,000 | +19.7% | 1,375,000 | +37.5% | 0.29% | +52.7% |
| PGNX | PROGENICS PHARMACEUTICALS IN | $31,350,000 | -25.3% | 8,250,000 | 0.0% | 0.27% | -4.9% | |
| Buy | CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $30,671,000 | +153.9% | 49,172,000 | +161.5% | 0.26% | +220.7% | |
| CARA | CARA THERAPEUTICS INC | $30,383,000 | -18.0% | 2,300,000 | 0.0% | 0.26% | +4.4% | |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $28,770,000 | +353.6% | 1,000,000 | +900.0% | 0.25% | +474.4% |
| FSCT | New | FORESCOUT TECHNOLOGIES INC | $27,641,000 | – | 875,000 | +100.0% | 0.24% | – |
| AVRO | Buy | AVROBIO INC | $26,841,000 | -14.0% | 1,725,000 | +11.3% | 0.23% | +9.0% |
| RDUS | RADIUS HEALTH INC | $26,708,000 | -35.5% | 2,054,486 | 0.0% | 0.23% | -18.2% | |
| ZEAL | Sell | ZEALAND PHARMA A Ssponsored adr | $25,875,000 | -22.8% | 750,000 | -25.7% | 0.22% | -1.8% |
| NVTA | Buy | INVITAE CORP | $25,635,000 | -9.2% | 1,875,300 | +7.2% | 0.22% | +15.2% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $25,645,000 | – | 1,335,000 | +100.0% | 0.22% | – |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $22,921,000 | -57.8% | 842,683 | -69.4% | 0.20% | -46.2% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $22,842,000 | +4.2% | 384,674 | -3.8% | 0.20% | +32.4% |
| Buy | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $22,499,000 | -2.8% | 25,500,000 | +45.7% | 0.19% | +23.7% | |
| TCDA | TRICIDA INC | $22,000,000 | -41.7% | 1,000,000 | 0.0% | 0.19% | -25.9% | |
| MYOK | Sell | MYOKARDIA INC | $20,158,000 | -86.5% | 430,000 | -79.0% | 0.17% | -82.8% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $19,386,000 | -46.3% | 675,000 | +35.0% | 0.17% | -32.0% |
| BX | New | BLACKSTONE GROUP INC | $18,356,000 | – | 402,811 | +100.0% | 0.16% | – |
| BRMK | New | BROADMARK RLTY CAP INCcall | $17,984,000 | – | 2,391,536 | +100.0% | 0.15% | – |
| New | THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $15,685,000 | – | 16,360,000 | +100.0% | 0.14% | – | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $14,844,000 | -30.4% | 350,000 | 0.0% | 0.13% | -11.8% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $14,500,000 | -83.6% | 3,625,000 | -12.1% | 0.12% | -79.2% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $12,765,000 | +131.5% | 1,500,000 | +348.2% | 0.11% | +197.3% |
| QURE | Buy | UNIQURE NV | $11,863,000 | -17.2% | 250,000 | +25.0% | 0.10% | +5.2% |
| STML | STEMLINE THERAPEUTICS INC | $11,374,000 | -54.5% | 2,350,000 | 0.0% | 0.10% | -42.0% | |
| KRYS | New | KRYSTAL BIOTECH INC | $10,810,000 | – | 250,000 | +100.0% | 0.09% | – |
| PTGX | PROTAGONIST THERAPEUTICS INC | $10,590,000 | +0.1% | 1,500,000 | 0.0% | 0.09% | +28.2% | |
| SVRA | SAVARA INC | $10,229,000 | -52.7% | 4,825,086 | 0.0% | 0.09% | -39.7% | |
| QTNT | QUOTIENT LTD | $9,875,000 | -58.5% | 2,500,000 | 0.0% | 0.08% | -46.9% | |
| VSTM | New | VERASTEM INC | $9,823,000 | – | 3,720,930 | +100.0% | 0.08% | – |
| AKBA | New | AKEBIA THERAPEUTICS INC | $9,475,000 | – | 1,250,000 | +100.0% | 0.08% | – |
| RC | Sell | READY CAP CORP | $9,154,000 | -63.3% | 1,267,896 | -21.6% | 0.08% | -53.0% |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $9,180,000 | -40.5% | 3,000,000 | 0.0% | 0.08% | -24.0% | |
| CYTK | New | CYTOKINETICS INC | $7,369,000 | – | 625,000 | +100.0% | 0.06% | – |
| Sell | DERMTECH INC | $6,809,000 | -10.8% | 605,255 | -1.6% | 0.06% | +11.5% | |
| ADSW | New | ADVANCED DISP SVCS INC DEL | $5,793,000 | – | 176,610 | +100.0% | 0.05% | – |
| RADIUS HEALTH INCnote 3.000% 9/0 | $4,821,000 | -16.7% | 6,750,000 | 0.0% | 0.04% | +5.1% | ||
| OPTN | Sell | OPTINOSE INC | $3,504,000 | -57.8% | 780,484 | -13.3% | 0.03% | -46.4% |
| BEAM | New | BEAM THERAPEUTICS INC | $3,063,000 | – | 170,164 | +100.0% | 0.03% | – |
| XRX | XEROX HOLDINGS CORP | $2,462,000 | -48.6% | 130,000 | 0.0% | 0.02% | -34.4% | |
| New | CTRIP COM INTL LTDnote 1.000% 7/0 | $1,948,000 | – | 2,000,000 | +100.0% | 0.02% | – | |
| New | CTRIP COM INTL LTDdbcv 1.990% 7/0 | $1,985,000 | – | 2,000,000 | +100.0% | 0.02% | – | |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $1,924,000 | – | 586,497 | +100.0% | 0.02% | – |
| BRMKWS | BROADMARK RLTY CAP INC*w exp 11/15/202 | $1,578,000 | -42.1% | 7,174,613 | 0.0% | 0.01% | -22.2% | |
| New | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $1,211,000 | – | 1,500,000 | +100.0% | 0.01% | – | |
| GOSS | Sell | GOSSAMER BIO INC | $1,015,000 | -87.0% | 100,000 | -80.0% | 0.01% | -83.0% |
| RVMD | New | REVOLUTION MEDICINES INC | $454,000 | – | 20,733 | +100.0% | 0.00% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $341,000 | -97.9% | 50,113 | -95.4% | 0.00% | -97.3% |
| GOL | New | GOL LINHAS AEREAS INTLG S Aspon adr pfd new | $367,000 | – | 85,838 | +100.0% | 0.00% | – |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $280,000 | -95.4% | 84,502 | -91.5% | 0.00% | -95.1% |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.01% | – |
| APTX | Exit | APTINYX INC | $0 | – | -408,549 | -100.0% | -0.01% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -1,808,360 | -100.0% | -0.01% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -2,500,000 | -100.0% | -0.02% | – |
| OYST | Exit | OYSTER POINT PHARMA INC | $0 | – | -230,800 | -100.0% | -0.04% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -2,000,000 | -100.0% | -0.04% | – |
| GCVRZ | Exit | SANOFIright 12/31/2020 | $0 | – | -9,195,584 | -100.0% | -0.05% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -354,082 | -100.0% | -0.05% | – |
| LOGM | Exit | LOGMEIN INC | $0 | – | -130,241 | -100.0% | -0.08% | – |
| XGN | Exit | EXAGEN INC | $0 | – | -577,699 | -100.0% | -0.10% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -600,000 | -100.0% | -0.10% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -75,000 | -100.0% | -0.10% | – |
| S | Exit | SPRINT CORPORATION | $0 | – | -3,200,000 | -100.0% | -0.11% | – |
| NLOK | Exit | NORTONLIFELOCK INC | $0 | – | -720,000 | -100.0% | -0.12% | – |
| CY | Exit | CYPRESS SEMICONDUCTOR CORP | $0 | – | -840,000 | -100.0% | -0.13% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -875,000 | -100.0% | -0.14% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -1,000,000 | -100.0% | -0.14% | – |
| INST | Exit | INSTRUCTURE INC | $0 | – | -620,000 | -100.0% | -0.20% | – |
| TIF | Exit | TIFFANY & CO NEW | $0 | – | -225,000 | -100.0% | -0.20% | – |
| MLNX | Exit | MELLANOX TECHNOLOGIES LTD | $0 | – | -270,000 | -100.0% | -0.21% | – |
| Exit | CYPRESS SEMICONDUCTOR CORPnote 4.500% 1/1 | $0 | – | -18,645,000 | -100.0% | -0.22% | – | |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -726,986 | -100.0% | -0.24% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -442,222 | -100.0% | -0.31% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -2,520,000 | -100.0% | -0.34% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -400,000 | -100.0% | -0.35% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -750,000 | -100.0% | -0.38% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -1,500,000 | -100.0% | -0.40% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -750,000 | -100.0% | -0.40% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -1,190,000 | -100.0% | -0.48% | – |
| AXE | Exit | ANIXTER INTL INC | $0 | – | -917,893 | -100.0% | -0.57% | – |
| SPGI | Exit | S&P GLOBAL INC | $0 | – | -640,382 | -100.0% | -1.18% | – |
| ZAYO | Exit | ZAYO GROUP HLDGS INC | $0 | – | -6,820,000 | -100.0% | -1.60% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -3,315,000 | -100.0% | -1.90% | – |
| SMH | Exit | VANECK VECTORS ETF TRUSTput | $0 | – | -2,505,000 | -100.0% | -2.39% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -2,400,000 | -100.0% | -5.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.